those with no CVD or renal disease), SGLT2 inhibitors are useful second-line agents if inadequate glycaemic control, particularly in overweight or obese patients where weight loss is beneficial
Protein intake deserves particular attention, with recommendations typically ranging from 1.0-1.2 grams per kilogram of body weight daily, individualized based on clinical status
Sources Molinoff PB, Shadiack AM, Earle D, Diamond LE, Quon CY
Alexis Pedrick: The jury is still out on whether Ozempics journey will end the same way that it ended for other weight loss drugs
[6] This is where people get confused
The search for drugs to treat these metabolic disorders has, therefore, intensified